Page last updated: 2024-10-24

buspirone and Gastric Stasis

buspirone has been researched along with Gastric Stasis in 2 studies

Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Research Excerpts

ExcerptRelevanceReference
"To determine if buspirone treatment improves early satiety and postprandial fullness in patients with symptoms of gastroparesis."9.69Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST). ( Abdullah, A; Abell, TL; Bulat, RS; Farrugia, G; Grover, M; Hamilton, F; Koch, KL; Kuo, B; Malik, Z; Maurer, AH; McCallum, RW; Miriel, LA; Parkman, HP; Pasricha, PJ; Sarosiek, I; Silver, P; Tonascia, J; Yates, KP, 2023)
"To determine if buspirone treatment improves early satiety and postprandial fullness in patients with symptoms of gastroparesis."5.69Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST). ( Abdullah, A; Abell, TL; Bulat, RS; Farrugia, G; Grover, M; Hamilton, F; Koch, KL; Kuo, B; Malik, Z; Maurer, AH; McCallum, RW; Miriel, LA; Parkman, HP; Pasricha, PJ; Sarosiek, I; Silver, P; Tonascia, J; Yates, KP, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Parkman, HP1
Yates, KP1
Sarosiek, I1
Bulat, RS1
Abell, TL1
Koch, KL1
Kuo, B1
Grover, M1
Farrugia, G1
Silver, P1
Abdullah, A1
Maurer, AH1
Malik, Z1
Miriel, LA1
Tonascia, J1
Hamilton, F1
Pasricha, PJ1
McCallum, RW1
Sayuk, GS1

Trials

1 trial available for buspirone and Gastric Stasis

ArticleYear
Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST).
    Alimentary pharmacology & therapeutics, 2023, Volume: 57, Issue:11

    Topics: Buspirone; Double-Blind Method; Female; Gastric Emptying; Gastroparesis; Humans; Male

2023

Other Studies

1 other study available for buspirone and Gastric Stasis

ArticleYear
Editorial: buspirone for gastroparesis-an intriguing option for a challenging condition.
    Alimentary pharmacology & therapeutics, 2023, Volume: 57, Issue:11

    Topics: Buspirone; Gastroparesis; Humans

2023